Drug delivery to the posterior eye segment is an important challenge in ophthalmology,
because many diseases affect the retina and choroid leading to impaired vision or …

As a naturally-occurring polysaccharide which could be found in various ophthalmic tissues,
hyaluronic acid (HA) has a wide range of applications in the eye, including treatment of dry …

Microencapsulation techniques have been intensively explored by many research sectors
such as pharmaceutical and food industries. Microencapsulation allows to protect the active …

Abstract Poly (lactide-co-glycolide)(PLGA) microspheres are efficient delivery systems for
controlled release of low molecular weight drugs as well as therapeutic macromolecules …

Long acting injectable formulations have been developed to sustain the action of drugs in
the body over desired periods of time. These delivery platforms have been utilized for both …

Long-acting injectable (LAI) formulations can provide several advantages over the more
traditional oral formulation as drug product opportunities. LAI formulations can achieve …

Multiple mechanisms are involved in driving the efficacy of drug delivery. Drug particle size
is one of the challenges as particles need to be delivered from the external environment, into …

Recent advances in pharmacological agents have led to successful treatment of a variety of
retinal diseases such as neovascular age-related macular degeneration (AMD), diabetic …

Glaucoma is a leading cause of irreversible visual impairment and blindness, affecting over
76.0 million people worldwide in 2020, with a predicted increase to 111.8 million by 2040 …

Intravitreal injections have become the most commonly performed intraocular treatments
worldwide. Because intravitreal injections may induce severe adverse events, such as …